Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial.
Koch G, Casula EP, Bonnì S, Borghi I, Assogna M, Minei M, Pellicciari MC, Motta C, D'Acunto A, Porrazzini F, Maiella M, Ferrari C, Caltagirone C, Santarnecchi E, Bozzali M, Martorana A.
Brain. 2022 Nov 21;145(11):3776-3786. doi: 10.1093/brain/awac285.
The Integrated Alzheimer's Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial.
Wessels AM, Andersen SW, Dowsett SA, Siemers ER.
J Prev Alzheimers Dis. 2018;5(2):134-136. doi: 10.14283/jpad.2018.10.
Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.
Park SH, Han KS.
Curr Alzheimer Res. 2022;19(3):202-211. doi: 10.2174/1567205019666220404104854.
Lecanemab Questions.
Nadeau SE.
Neurology. 2024 Apr 9;102(7):e209320. doi: 10.1212/WNL.0000000000209320. Epub 2024 Mar 14.
Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease.
Sabbagh M, Sadowsky C, Tousi B, Agronin ME, Alva G, Armon C, Bernick C, Keegan AP, Karantzoulis S, Baror E, Ploznik M, Pascual-Leone A.
Alzheimers Dement. 2020 Apr;16(4):641-650. doi: 10.1016/j.jalz.2019.08.197. Epub 2020 Jan 16.
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.
Kueper JK, Speechley M, Montero-Odasso M.
J Alzheimers Dis. 2018;63(2):423-444. doi: 10.3233/JAD-170991.
Shortening the Alzheimer's disease assessment scale cognitive subscale.
Levine SZ, Goldberg Y, Rotstein A, Samara M, Yoshida K, Cipriani A, Iwatsubo T, Leucht S, Furukawa TA.
Eur Psychiatry. 2024 Feb 23;67(1):e19. doi: 10.1192/j.eurpsy.2024.14.
Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog): Normative Data for the Portuguese Population.
Nogueira J, Freitas S, Duro D, Tábuas-Pereira M, Guerreiro M, Almeida J, Santana I.
Acta Med Port. 2018 Feb 28;31(2):94-100. doi: 10.20344/amp.8859. Epub 2018 Feb 28.
State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) in mild Alzheimer's disease.
Cogo-Moreira H, Krance SH, Wu CY, Lanctôt KL, Herrmann N, Black SE, MacIntosh BJ, Rabin JS, Eid M, Swardfager W; Alzheimer's Disease Neuroimaging Initiative.
Alzheimers Dement (N Y). 2023 Mar 26;9(1):e12376. doi: 10.1002/trc2.12376. eCollection 2023 Jan-Mar.
Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis.
Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R.
Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10.
